| 前收市價 | 207.10 |
| 開市 | 206.60 |
| 買盤 | 0.00 x 10000 |
| 賣出價 | 0.00 x 10000 |
| 今日波幅 | 206.60 - 209.80 |
| 52 週波幅 | 178.30 - 257.20 |
| 成交量 | |
| 平均成交量 | 27 |
| 市值 | 30.546B |
| Beta 值 (5 年，每月) | -0.04 |
| 市盈率 (最近 12 個月) | 28.31 |
| 每股盈利 (最近 12 個月) | 7.41 |
| 業績公佈日 | 2024年7月23日 - 2024年7月29日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 413.19 |
Investor's Business DailyBiden Just Knocked Eli Lilly Stock Off Its Pedestal — Is It A Buy Or A Sell?
Is Eli Lilly stock a buy or a sell after Joe Biden called out Lilly and Novo Nordisk for high drug prices? Is LLY stock a buy or a sell?
Investor's Business DailyEli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug
Eli Lilly won FDA approval for its Alzheimer's treatment, donanemab, on Tuesday. But Eli Lilly stock remained in the red.
Insider MonkeyBiogen (BIIB) Slipped on Lower-Than-Expected Revenue Growth
ClearBridge Investments, an investment management company, released its “ClearBridge Value Equity Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The strategy outperformed the Russell 1000 Value Index in the first quarter. On an absolute basis, the strategy has gained 9 out of eleven sectors it invested in during […]
